Laboratorios Rovi ha anticipado este viernes que su EBITDA de 2024 será entre un 10% y un 15% inferior a lo previsto por el ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback